An 84-year-old East Sussex resident successfully recovered £102 after being defrauded by a fake online pharmacy. The victim attempted to purchase pain medication through a deceptive website but received no products in return.
Lorem ipsum and fake pharmacists at LoyaltyPharma.com
The fraud began when a resident of East Sussex, identified as J.F., used an internet search to find a site called LoyaltyPharma.com. Seeking 200 Zapain tablets for serious back pain, the customer transferred £102 to an individual identified as D.M. However, the medication never arrived, and the seller ignored all follow-up emails, as the report says.
Upon closer inspection, LoyaltyPharma.com exhibited classic hallmarks of a phishing operation. While the site featured professional imagery of pharmacists and medicine shelves, much of its actual text was "Lorem ipsum" placeholder content. Additionally, the site used a name designed to mimic a legitimate pharmacy and provided a non-functional contact email address.
The most critical warning sign was the payment method. According to the source, the site requested bank transfers, PayPal, or cryptocurrency. Paying a named individual rather than a registered business entity is a primary red flag for financial fraud in the digital marketplace.
Santander's reversal of the £100 excess charge
The recovery of the funds involved a contentious interaction with Santander. Initially , the bank agreed that J.F. had been defrauded but proposed a £100 excess deduction. This would have left the 84-year-old victim with a mere £2 reimbursement from the original £102 loss.
Santander eventually reversed this decision and issued a full refund after the customer's specific circumstances were reviewed. The bank recognized the customer as vulnerable due to their age, the severity of their back pain, and the urgent need for medication. Santander subsequently apologized and stated the reimbursement aligned with the mandatory requirements of the Payment Systems Regulator.
The October 2024 APP fraud reimbursement rules
This case serves as a practical application of the Authorised Push Payment (APP) fraud reimbursement rules that came into effect in October 2024. These regulations are designed to protect consumers who are tricked into authorizing payments to scammers, providing a maximum reimbursement ceiling of £85,000 under specific conditions.
The shift toward mandatory reimbursement reflects a broader trend in the UK financial sector to hold banks more accountable for the flow of fraudulent funds.. By requiring institutions like Santander to compensate victims, regulators aim to incentivize banks to improve their detection systems and warn customers more effectively before a transfer is completed.
The identity of D.M. and the risk of counterfeit Zapain
Significant questions remain regarding the recipient of the funds, identified only as D.M. The report notes that the identity of this individual was withheld because searches for the name led to a phishing website designed to steal personal and financial data. This suggests that the pharmacy scam was likely part of a larger, multi-layered criminal infrastructure.
Beyond the financial loss, the case highlights a dangerous public health risk. Fraudulent sites like LoyaltyPharma.com may not simply steal money; they may ship counterfeit or unsafe medicines.. To avoid this, the source advises consumers to verify that any online seller is registered with the General Pharmaceutical Council or regulated by the Medicines and Healthcare products Regulatory Agency (MHRA).
While HSBC , the bank that accepted the payment for the fraudster, stated it takes immediate action against accounts used for criminal purposes, the ease with which the account was opened remains a point of concern for consumer advocates.
Comments 0